期刊文献+

促甲状腺激素正常的新诊断2型糖尿病患者BMI对糖、脂代谢,肝肾、甲状腺功能的影响 被引量:6

Effects of body mass index on glucose and lipid metabolism,hepatic,renal and thyroid function in newly diagnosed type 2 diabetes mellitus patients with normal serum TSH
下载PDF
导出
摘要 目的:探讨促甲状腺激素正常的新诊断2型糖尿病患者体重指数(body mass index,BMI)与糖、脂代谢,肝肾、甲状腺功能的关系。方法:收集2016年1月—2017年12月本院内分泌门诊156例促甲状腺激素正常的新诊断2型糖尿病患者的临床资料,按照BMI水平分为肥胖组(BMI≥28.0 kg/m2)、超重组(24.0 kg/m2≤BMI<28.0 kg/m2)、正常组(BMI<24.0 kg/m2)。分析3组患者各项代谢指标的差异以及BMI与各代谢指标的关系。结果:3组患者的丙氨酸氨基转移酶(ALT)、γ-谷氨酰转肽酶(γ-GT)、总胆固醇(TC)、空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)、空腹C肽(CP)、血浆促甲状腺激素(TSH)差异有统计学意义(P <0.05)。相关分析表明,在校正性别、年龄、糖化血红蛋白(HbA1c)后,随着BMI的升高,ALT、γ-GT、FINS、HOMAIR、CP、TSH也升高,呈正相关(r=0.22、0.19、0.36、0.38、0.27、0.22,P <0.05)。结论:TSH正常的新诊断2型糖尿病患者的BMI水平对机体相关代谢指标如ALT、γ-GT、TC、FINS、HOMA-IR、CP、TSH均有影响,且BMI水平与ALT、γ-GT、FINS、HOMA-IR、CP、TSH水平呈正相关。可将TSH水平作为评估新诊断的2型糖尿病患者,特别是肥胖的2型糖尿病人群代谢紊乱的参考指标和并发症随访观察的指标,及时给予适当干预。 Objective:To explore the relationship between body mass index(BMI)and different metabolic variables(glucose and lipid metabolism,hepatic,renal and thyroid function)in newly diagnosed type 2 diabetes mellitus patients with normal serum TSH.Methods:We retrospectively collected clinical data from 156 newly diagnosed type 2 diabetes mellitus patients with normal serum TSH in our center,including gender,age,BMI,alanine aminotransferase(ALT),γ-glutamyltransferase(γ-GT),blood urea nitrogen(BUN),creatinine(Cr),uric acid(UA),fasting plasma glucose(FPG),fasting C-peptide(CP),fasting insulin(FINS),glycosylated hemoglobin A1 c(HbA1 c),insulin resistance(HOMA-IR),triglyceride(TG),total cholesterol(TC),low-density lipoprotein cholesterol(LDL-C),high-density lipoprotein cholesterol(HDL-C),free triiodothyronine(FT3),free thyroxin(FT4),thyroid stimulating hormone(TSH).All the patients were divided into the obesity group(BMI≥28.0 kg/m2),the overweight group(24.0 kg/m2≤BMI<28.0 kg/m2)and the normal weight group(BMI<24.0 kg/m2)according to BMI.The differences of metabolic variables among three groups and the correlation between BMI and different metabolic variables were analyzed.Results:Levels of ALT,γ-GT,TC,FINS,HOMA-IR,CP and TSH among groups were significantly different(P<0.05).After adjustment for gender,age and HBA1 c,levels of ALT,γ-GT,FINS,HOMA-IR,CP and TSH increased with the increase of BMI(r=0.22,0.19,0.36,0.38,0.27,0.22,P<0.05).Conclusion:BMI could significantly affect ALT,γ-GT,TC,FINS,HOMA-IR,CP and TSH in newly diagnosed type 2 diabetes mellitus patients with normal serum TSH.Besides,ALT,γ-GT,FINS,HOMA-IR,CP and TSH were positively correlated with BMI.TSH level could serve as an index in evaluating metabolic disorder and follow-up in newly diagnosed type 2 diabetes mellitus,especially with obesity.
作者 方达 刘颖 马向华 Fang Da;Liu Ying;Ma Xianghua(Department of Endocrinology,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China;Department of Nutriology,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China)
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2019年第5期700-703,726,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省中医药局科技项目(YB2015164)
关键词 2型糖尿病 肥胖 甲状腺激素 type 2 diabetes mellitus obesity thyroid hormones
  • 相关文献

参考文献2

二级参考文献16

  • 1Hage M, Zantout MSM, Azar ST. Tyroid disorders and diabetes mellitus. J Thyroid Res,2011,2011:439-463.
  • 2Umpierrez GE, Latif KA, Murphy MB, et al. Thyroid dysfunction in patients with type 1 diabetes. Diabetes Care ,2003,26 : 1181-1185.
  • 3Gharib H, Turtle RM, Baskim J,et al. Consensus statement, subclinical thyroid dysfunction: a joint statementon management from the american association of clinicalendocrinologists, the american thyroid association and the endocrine society. J Clin Endocrinol Metab,2005,90:581-585.
  • 4Vondra K, Vrbikova J, Dvorakova K. Thyroid gland diseases in adult patients with diabetes mellitus. Minerva Endocrino1,2005 ,30 :217-236.
  • 5Radaideh AR, Nusier MK, AmariFI, et al. Thyriod dysfunction in patients with type 2 diabetes mellitus in Jordan. Saudi Med J, 2004.25 : 1046- 1050.
  • 6Diez J J, Anchez PS, Lglesias P. Prevalence of thyroid dysfunction in patients with type 2 diabetes, exp Clin Endocrinol diabetes, 2011,119 : 201-207.
  • 7Owecki M,EIAli Z,Nikisch E,et al. Serum insulin levels and thedegree of thyroid dysfunction in hypothyroid women. Neuro Endocrinol Lett, 2008,29 : 137-140.
  • 8Benedict RH, Bobholz JH. Multiple Sclerosis. SeminNeurol, 2007,27 : 78-85.
  • 9Hollowell JG, Stachlin NW, Flanders WD, et al. Serum TSH, T4, and thyroidantibodies in the United States Population (1988-1994) : Nationa Health and Nutrition Examination Survey ( NHANES Ⅲ ). J Clin Endo- erinol Metab,2002,87:489-499.
  • 10Habibs S, Ali A. Biochemistry of nitric oxide. Indian J Clin Biochem, 2011,26:3-17.

共引文献15

同被引文献51

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部